Table 4.
Hematological parameters among the study groups.
| Group | SS | AS | AA | p value |
|---|---|---|---|---|
| WBC (×109/L) | 18.06 ± 8.45a | 7.55 ± 3.96b | 6.19 ± 1.81b | ≤0.001∗ |
| Lymph (×109/L) | 8.38 ± 4.68a | 3.50 ± 2.29b | 2.85 ± 0.94b | ≤0.001∗ |
| Mon (×109/L) | 1.89 ± 0.85a | 0.78 ± 0.52b | 0.57 ± 0.21c | ≤0.001∗ |
| Gran (×109/L) | 7.79 ± 5.23a | 3.26 ± 1.57b | 2.77 ± 1.04b | ≤0.001∗ |
| Lymph% | 46.2 ± 10.5a | 45.5 ± 8.6a | 46.3 ± 8.4a | 0.880 |
| Mon% | 10.9 ± 3.5a | 10.4 ± 3.2a,b | 9.3 ± 2.3b | ≤0.005∗ |
| Gran% | 42.8 ± 10.8a | 44.0 ± 8.6a | 44.4 ± 8.6a | 0.523 |
| Hb (g/dL) | 7.49 ± 1.32c | 11.66 ± 2.03b | 12.5 ± 1.10a | ≤0.001∗ |
| RBC (×1012/L) | 2.98 ± 0.68c | 4.77 ± 0.84b | 5.08 ± 0.43a | ≤0.001∗ |
| HCT (%) | 27.0 ± 5.0c | 40.5 ± 6.6b | 43.0 ± 3.36a | ≤0.001∗ |
| MCV (fL) | 91.1 ± 12.8a | 85.7 ± 8.1b | 85.0 ± 5.6b | ≤0.001∗ |
| MCH (pg) | 25.64 ± 3.05a | 24.55 ± 2.32b | 24.46 ± 2.17b | ≤0.001∗ |
| MCHC (g/dL) | 27.91 ± 1.50b | 28.69 ± 0.86a | 28.99 ± 0.72a | ≤0.001∗ |
| RDW-CV% | 23.4 ± 3.4a | 16.2 ± 3.9b | 14.3 ± 1.2c | ≤0.001∗ |
| RDW-SD (fL) | 76.5 ± 13.4 | 50.5 ± 11.9 | 45.7 ± 4.3 | ≤0.001∗ |
| PLT (×109/L) | 469 ± 181a | 333 ± 150b | 283 ± 78b | ≤0.001∗ |
| MPV (fL) | 9.83 ± 0.67b | 10.14 ± 0.66a | 10.05 ± 0.84a,b | ≤0.05∗ |
| PDW | 14.7 ± 0.3 | 14.5 ± 0.2 | 14.6 ± 0.2 | 0.175 |
| PCT% | 7.51 ± 0.9 | 0.31 ± 0.09 | 0.28 ± 0.07 | 0.522 |
WBC: white blood cells; RDW: red cell distribution width; PDW: platelet distribution width; PCT: platelet crit; a, b, and c: values with different letters in the same line are significantly different at p < 0.05; ANOVA with post hoc Dunnet T3.